Inventor
FRIDKIN MATITYAHU
IL34 patents
⚠️ This page may combine multiple inventors who share the name “FRIDKIN MATITYAHU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YEDA RES & DEV
30 patentsUS7585837B2Sep 8, 2009
Reversible pegylated drugs
YEDA RES & DEV182 citations98
US5736146AApr 7, 1998
Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
YEDA RES & DEV111 citations96
US6504005B1Jan 7, 2003
Long-acting drugs and pharmaceutical compositions comprising them
YEDA RES & DEV59 citations94
US5869058AFeb 9, 1999
Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
YEDA RES & DEV73 citations94
US8877709B2Nov 4, 2014
Reversible pegylated drugs
YEDA RES & DEV18 citations92
US8735350B2May 27, 2014
Reversible pegylated drugs
YEDA RES & DEV17 citations92
US8343910B2Jan 1, 2013
Reversible pegylated drugs
YEDA RES & DEV21 citations92
US6239107B1May 29, 2001
Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
YEDA RES & DEV47 citations92
US5972883AOct 26, 1999
Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof
YEDA RES & DEV37 citations92
US5147855ASep 15, 1992
Conjugates of vip and active fragments thereof with hydrophobic moieties and topical compositions for male impotence
YEDA RES & DEV36 citations92
US7906620B2Mar 15, 2011
Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
YEDA RES & DEV19 citations91
US7084249B1Aug 1, 2006
Tumor associated antigen peptides and use of same as anti-tumor vaccines
YEDA RES & DEV19 citations90
US7182945B2Feb 27, 2007
Anti-inflammatory peptides derived from C-reactive protein
YEDA RES & DEV18 citations89
US6528618B1Mar 4, 2003
Anti-inflammatory peptides derived from C-reactive protein
YEDA RES & DEV22 citations89
US6414029B1Jul 2, 2002
Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
YEDA RES & DEV44 citations88
US6180103B1Jan 30, 2001
Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
YEDA RES & DEV18 citations84
US9119883B2Sep 1, 2015
Reversible pegylated drugs
YEDA RES & DEV5 citations83
US7795224B2Sep 14, 2010
Tumor associated antigen peptides and use of same as anti-tumor vaccines
YEDA RES & DEV8 citations82
US4085261AApr 18, 1978
Organic reagents and process of preparing same
YEDA RES & DEV20 citations80
US6906170B1Jun 14, 2005
Anti-inflammatory peptides derived from IL-2 and analogues thereof
YEDA RES & DEV15 citations79
US5998368ADec 7, 1999
Derivatives of structurally modified VIP and pharmaceutical compositions containing them
YEDA RES & DEV14 citations74
US7960507B2Jun 14, 2011
Tumor associated antigen peptides and use of same as anti-tumor vaccines
YEDA RES & DEV4 citations71
US4215219AJul 29, 1980
Reagents from phenolic and 8-hydroxyquinolinic aldehyde oximes
YEDA RES & DEV6 citations71
US3974110AAug 10, 1976
Modification of polystyrene by Friedel-Crafts reaction with substituted halo ethyl benzenes and haloethylphenols to make supports for solid phase peptide synthesis
YEDA RES & DEV9 citations70
US9956295B2May 1, 2018
Reversible pegylated drugs
YEDA RES & DEV1 citations62
US9433683B2Sep 6, 2016
Reversible pegylated drugs
YEDA RES & DEV1 citations62
US7531629B2May 12, 2009
Tumor associated antigen peptides and use of same as anti-tumor vaccines
YEDA RES & DEV3 citations61
US9567371B2Feb 14, 2017
Short beta-defensin-derived peptides
YEDA RES & DEV1 citations49
US9382293B2Jul 5, 2016
Modified kisspeptin peptides and uses thereof
YEDA RES & DEV0 citations49
US10072044B2Sep 11, 2018
Modified kisspeptin peptides and uses thereof
YEDA RES & DEV0 citations42